The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Estimating the Number of Persons with Frontotemporal Lobar Degeneration in the US Population
Open accessAbstract
There are many challenges for determining the prevalence and incidence of frontotemporal lobar degenerations (FTLD). Consequently, the number of cases of behavioral variant frontotemporal dementia (bvFTD) or primary progressive aphasia (PPA) in the USA is unknown. Our objective was to derive a consensus estimate of bvFTD and PPA prevalence and thereby to estimate the total number of these syndromes in the USA. We identified five prevalence and three incidence studies of FTLD based on passive surveillance and seven studies of survival in FTLD. Data from these studies were used to estimate the number of cases of PPA or bvFTD in the USA. Because prevalence and incidence estimates outside of the 45-64-year age range were either not available or widely divergent, we used data from clinical and pathological series to estimate the proportion of FTLD cases aged <45 or >64 years. The prevalence estimates in the age categories of 45-64 years old have ranged from 15 to 22 per 100,000 person-years in studies where both bvFTD and PPA were identified. The incidence estimates for the same age group ranged from 2.7 to 4.1 per 100,000 person-years. Using a survival rate of 6 to 9 years from onset and rates from the incidence studies, a calculated prevalence estimate (prevalence = incidence × duration) was similar to the previously reported prevalence rates. We estimated that 10% of cases were less than age 45 years and 30% were 65 years and older. We estimate that there are approximately 20,000 to 30,000 cases of the cognitive syndromes of FTLD in the USA. The main threat to the accuracy of the estimates is the difficulty in diagnosing the clinical syndromes that comprise the FTLD group of disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Self-citationFrontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Weıntraub, S. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120075013 · Cited by 3,018
Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331
The prevalence of frontotemporal dementia
Ratnavalli, E., Brayne, C., Dawson, K. E., & Hodges, J. R. (2002) · Neurology · doi:10.1212/wnl.58.11.1615 · Cited by 1,182
Incidence of amyotrophic lateral sclerosis in Europe
Logroscino, G., Traynor, B. J., Hardiman, O., Chio, A., Mitchell, D., Swingler, R. J., Millul, A., Benn, E., Beghi, E., & EURALS, F. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.183525 · Cited by 772
Barker, W., Luis, C. A., Kashuba, A., Luis, M., Harwood, D. G., Loewenstein, D., Waters, C., Jimison, P., Shepherd, E., Sevush, S., et al. (2002) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200210000-00001 · Cited by 714
The prevalence and causes of dementia in people under the age of 65 years
Harvey, R. J. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1206 · Cited by 650
Clinicopathological correlates in frontotemporal dementia
Hodges, J. R., Davies, R. R., Xuereb, J. H., Casey, B., Broe, M., Bak, T. H., Kril, J. J., & Halliday, G. M. (2004) · Annals of Neurology · doi:10.1002/ana.20203 · Cited by 580
Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia
Mesulam, M., Wicklund, A., Johnson, N., Rogalski, E., Léger, G. C., Rademaker, A., Weintraub, S., & Bigio, E. H. (2008) · Annals of Neurology · doi:10.1002/ana.21388 · Cited by 513
Research works printed but not linked: 1
- Rascovsky K, Hodges JR, Knopman D, Mendez M, Kramer JH, Van Swieten JC et al (2011) Sensitivity of diagnostic criteria for autopsy-confirmed patients with behavioral variant frontotemporal dementia (bvFTD): first report of the international bvFTD criteria consortium (FTDC). Neurology 76(Suppl 4):A262–A263
Cited by
Sorted by citations
Items 201–238 of 238
Neurofilaments as biomarkers of neuronal damage
Pujol-Calderón, F. (2019)
Musser, W. S., Kofler, J., Becker, J. T., & López, O. L. (2021) · Cambridge University Press eBooks · doi:10.1017/9781316941294.018
Χατζηδημητρίου, Η. Ά. (2021) · Aristotle University of Thessaloniki · doi:10.26262/heal.auth.ir.326417
Ghosh, S., Shaftel, S. S., Kyrkanides, S., Olschowka, J. A., & O’Banion, M. K. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.10.430570
Voxel-Based Morphometry in Frontotemporal Dementia
Akhmadullina, D. R., Shpilyukova, Y. A., Коновалов, Р. Н., Fedotova, E. Y., & Illarioshkin, S. N. (2020) · Human Physiology · doi:10.1134/s0362119720080137
Lee, C. (2021) · cIRcle (University of British Columbia) · doi:10.14288/1.0400595
Neurology, S., Shanmugam, S., Hazeena, P., Neurology, S., Chalasani, V., Ghosh, A., Venkatasubramanian, S., Neurology, S., Venkatachalapathy, E., & Nuclear Medicine & PET CT, S. (2021) · Romanian Journal of Neurology · doi:10.37897/rjn.2021.2.10
The Minister, His Ferrari and His New Wife
Abdulrazaq, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-92983-1_10
Family caregivers of persons with young-onset dementia
Bruinsma, J. (2022) · doi:10.26481/dis.20220420jb
Villalobos-Nova, K., Monroy-Moya, S., Maulen-Peñaloza, J., Pinto, G. C. M., & Cornejo, A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220508175340
Pang, S. Y.-Y., & Miller, B. L. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.010
Misquitta, K., Rosen, H. J., & Tartaglia, M. C. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.004
Ettinger, A. B., Weisbrot, D. M., & Gallimore, C. E. (2019) · Cambridge University Press eBooks · doi:10.1017/9781107706866.006
Analysis of Adult Hippocampal Neurogenesis in Neurodegenerative disease
HAN, G. (2022) · Cronfa (Swansea University) · doi:10.23889/suthesis.62147
Machine learning techniques for MRI feature-based detection of frontotemporal lobar degeneration
Pilipenko, T., Gnutti, A., Silvestri, A., Serina, I., & Leonardi, R. (2022) · Procedia Computer Science · doi:10.1016/j.procs.2022.09.187
Daffron, G., & Ladenika, A. (2023) · Research Square · doi:10.21203/rs.3.rs-3258879/v1
Chang, J., Choi, Y., & Chang, C. H. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4578490
Distribution of neuropsychiatric profiles and comorbid diseases in dementia subtypes
Bülbül, N. G., Karşıdağ, S., Çınar, N., Ateş, M. F., Şahin, Ş., Karalı, F. S., Öner, Ö. G., Okluoglu, T., Eren, F., OKUYAN, D. Y., et al. (2024) · The European Research Journal · doi:10.18621/eurj.1386582
Major or Mild Frontotemporal Neurocognitive Disorder
Bourgeois, J. A., Hategan, A., Hirsch, C. H., & Howarth, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-47802-4_19
Major Neurocognitive Disorders Due to Frontotemporal Disease
Gopalakrishna, G., Sarangi, A., & Joshi, P. (2024) · Springer eBooks · doi:10.1007/978-3-031-55711-8_4
Sawyer, R. P., Doran, S., & Miller, B. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00032-7
Gerhand, S. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009025911.009
Frontotemporal Dementia, Current Diagnosis and Treatment Emphasis on Natural Products: A Review
Nooreen, Z., Sumayya, F., Wal, P., Rai, A. K., & Tandon, S. (2025) · Current Aging Science · doi:10.2174/0118746098343389250131050235
Language in behavioral variant frontotemporal dementia
Géraudie, A., & Montembeault, M. (2025) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780198888482.013.0017
Su, J., Noya, J. A., Lingappa, A. F., Solas, D., Tong, J., Daughrity, L. M., Castanedes‐Casey, M., Kurti, A., Dickson, D. W., Lingappa, V. R., et al. (2025) · Cells · doi:10.3390/cells14242012
Additional file 1 of Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia
Kurnellas, M., Mitra, A., Schwabe, T., Paul, R., Arrant, A. E., Roberson, E. D., Ward, M., Yeh, F. L., Long, H., & Rosenthal, A. (2024) · Figshare · doi:10.6084/m9.figshare.26597423
Boutoleau‐Bretonnière, C. (2015) · theses.fr (ABES) · doi:10.70675/85cf2bf3zce07z46cbzb836zf9cda8e7cde4
Laillier, R. (2019) · theses.fr (ABES) · doi:10.70675/f3f3322dz8127z47daz997fz61e5af74e307
Sanches, M. C. P. (2019) · theses.fr (ABES) · doi:10.70675/23d3688fza2a5z4b5czace8z77e89e074aaf
Neuroinflammation- molecular target based therapeutic approach
Paul, D. (2026) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2026.04.006
Leveraging centrality metrics for the early detection of dementias
Thulaseedharan, S. S., Suvish, Ghamari, M., Sheela, P., Das, S., & Kumar, R. S. (2026) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2026.109518
Progranulin haploinsufficiency remodels the cerebral microvasculature and neurovascular unitPreprint
Chakraborty, S., Weick, M., Franciosa, S. A., Tabrizi, Z., Swinehart, C., Moore, G. R., Lee, D., Bhatt, N. N., Cano, A., Poorva, P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.20.738719
Takasaki, A., Suzuki, M., Taomoto, D., Hashimoto, M., & Ikeda, M. (2026) · Higher Brain Function Research · doi:10.2496/hbfr.46.108
Almeida, M. R., Tábuas‐Pereira, M., Matos, A., Santos, A., Teixeira, C., Baldeiras, I., Lima, M., & Santana, I. J. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1913909
BindingDB Entry 50018549: Discovery of oxazoline enhancers of cellular progranulin release.
BindingDB (2024) · UC San Diego · doi:10.7270/q2pr816j
BindingDB Entry 50013977: Discovery of quinuclidine modulators of cellular progranulin.
BindingDB (2022) · UC San Diego · doi:10.7270/q2bg2srp
Metadata
- Authors
- Knopman, D. S., & Roberts, R. O.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Knopman, David S.
- ORCID
- Knopman, David S.
- Venue
- Journal of Molecular Neuroscience
- Published
- 2011-05-17
- Volume
- 45
- Issue
- 3
- Pages
- 330-335
- ISSN
- 0895-8696 (ISSN-L)
- 1559-1166
- PMC
- PMC3208074
- OpenAlex
- W2074608237
- Cited by
- 236
- References
- 32
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 17 · 2023: 19 · 2022: 22 · 2021: 24 · 2020: 20 · 2019: 19 · 2018: 8 · 2017: 24 · 2016: 14 · 2015: 14 · 2014: 14 · 2013: 14 · 2012: 4
- FWCI
- 7.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Molecular Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Abbott Laboratories
- Eli Lilly and Company
- National Institutes of Health
- National Institute on Aging (P50‐AG16574, U01AG06786, U01AG006786, R01AG023195, P50AG016574)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- frontotemporal lobar degeneration, behavioral variant frontotemporal dementia, primary progressive aphasia, prevalence estimation, incidence estimation, age distribution of cases, United States
- MeSH terms
- Adult, Aged, Humans, Middle Aged, United States, Cohort Studies, Survival Rate, Aphasia, Primary Progressive, Frontotemporal Lobar Degeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
